Skip to main content
Premium Trial:

Request an Annual Quote

Dennis Gilbert, Nina Fedoroff, Ira Marks, Jerry Zemaitis, Joseph Keegan, Gus Davis, Lubert Stryer

Dennis Gilbert has resigned as chief scientific officer and vice president of research at Applied Biosystems, according to an ABI spokesman who confirmed via e-mail that Gilbert left the company as of Aug. 1 to “pursue other career interests.”
 

 
Nina Fedoroff has resigned from the board of directors of Sigma-Aldrich after being named Science and Technology Adviser to Secretary of State Condoleezza Rice. Fedoroff was nominated by the National Academy of Sciences.
 

 
Prodesse has named Ira Marks to its board of directors. Marks was a senior executive at Bio-Rad Laboratories, and over the years he has worked at Nanogen and Cepheid. Marks currently serves as GM of MiltenyiBiotec.
 

 
High Throughput Genomics has tapped Jerry Zemaitis to be vice president of commercial operations. In this new position, Zemaitis will handle strategic agreements and partnerships with businesses and with academic institutions.
 
Zemaitis previously was VP of sales at SeraCare and was involved in business development at Caliper Technologies and at Aclara BioSciences. He most recently was founder of Zeta Strategic Consulting.
 

 
Alpha Innotech has elected Joseph Keegan and Gus Davis to be independent directors on the company’s board of directors. Keegan formerly was CEO of Molecular Devices. Davis was COO of BioSource International, and he held senior posts at Amersham and Pharmacia Biotechnology.
 

 
Lubert Stryer, a professor of cell biology at StanfordUniversity and chairman of Affymetrix’s scientific advisory board, was awarded the 2006 National Medal of Science in a ceremony at the White House on July 27.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.